 NEW YORK, March 19, 2021 PRNewswire -- Juan Monteverde , founder and managing partner at Monteverde Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating GenMark Diagnostics, Inc. GNMK or the Company GNMK relating to its proposed acquisition by Roche Holdings, Inc. Under the terms of the agreement, GNMK shareholders will receive 24.05 per share in cash. The investigation focuses on whether GenMark Diagnostics, Inc. and its Board of Directors violated securities laws andor breached their fiduciary duties to the Company by 1 failing to conduct a fair process, and 2 whether the transaction is properly valued. 